Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy
NCT07706088Phase 4Not yet recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jul 2026
- Primary completion
- Jul 2028
01
Overview
Phase 4, randomised, open-label trial in diabetic peripheral neuropathy (DPN) comparing Tirzepatide + Standard of Care with Standard of Care (2 arms). Primary endpoint: Corneal Nerve Fiber Density at 6 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07706088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706088.